idiopathic pulmonary fibrosis

Predictive variables to obtain a bronchoalveolar lavage of adequate quality in patients with interstitial lung diseases
Pilar Rivera Ortega, Alexis Papadopoulos, Julie Martin, Christopher Craig, Andrew Cheng, Conal Hayton, Colm Leonard, Nazia Chaudhuri, Angeles Montero

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4790; DOI: 10.1183/13993003.congress-2019.PA4790
Spirometric evaluation of idiopathic pulmonary fibrosis (IPF): forced or slow vital capacity?
Juan José Rodríguez Moncalvo, José Malet Ruiz, Marcelo Mastroianni, Marina Khoury, Fabian Caro

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4703; DOI: 10.1183/13993003.congress-2019.PA4703
Health-related quality of life development in IPF versus other ILD – the HILDA study
Boglárka Szentes, Phillen Maqhuzu, Michael Kreuter, Thomas Bahmer, Martin Claussen, Larissa Schwarzkopf

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4722; DOI: 10.1183/13993003.congress-2019.PA4722
Hypersensitivity Pneumonitis in North Indian population
Ankit Kumar Sinha

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4737; DOI: 10.1183/13993003.congress-2019.PA4737
The role of lung ultrasonography in the assessment of idiopathic pulmonary fibrosis –correlation with HRCT finding
Milena Adina Man, Bianca Domokos Gergely, Andrei Lesan, Doina Adina Todea, Carmen Monica Pop, Nicoleta Stefania Motoc

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4696; DOI: 10.1183/13993003.congress-2019.PA4696
Plasma levels of circulating cell-free DNA are increased in idiopathic pulmonary fibrosis but do not correlate with disease severity
Marialuisa Bocchino, Umberto Malpelle, Domenico Galati, Serena Zanotta, Francesco Pepe, Pierlorenzo Pallante

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4695; DOI: 10.1183/13993003.congress-2019.PA4695
Clinical course of IPF Italian patients during 12-month of observation: results from the FIBRONET observational study
Venerino Poletti, Carlo Vancheri, Carlo Albera, Sergio Harari, Alberto Pesci, Paola Rottoli, Benedetta Campolo, De Santi Lorenzo, Roncari Barbara On Behalf Of Fibronet Study Group

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4708; DOI: 10.1183/13993003.congress-2019.PA4708
Lung biopsy in patients with suspected idiopathic pulmonary fibrosis and probable interstitial pneumonia on the CT scan
Lluisa Ramon Clar, Maria Isabel Luna Lopez, Belén Núñez Sánchez, Ernest Sala Llinàs, Cristina Oliver Terrassa, Juan Antonio Palmer Sancho, Cristina Gomez Bellvert, Angel Francisco Carvajal Carrasco, Jaume Sauleda Roig

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4689; DOI: 10.1183/13993003.congress-2019.PA4689
Healthcare resource utilization and direct costs of interstitial lung disease management in Germany
Phillen Maqhuzu, Larissa Schwarzkopf, Michael Kreuter

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4721; DOI: 10.1183/13993003.congress-2019.PA4721
Treatment and survival diversities in different forms of ILD in Germany - EXCITING registry
Michael Kreuter, Hans-Joachim Kabitz, Lars Hagmeyer, Peter Hammerl, Albert Esselmann, Conrad Wiederhold, Dirk Skowasch, Christoph Stolpe, Marcus Joest, Stefan Veitshans, Phillen Maqhuzu, Larissa Schwarzkopf, Andreas Hellmann, Michael Pfeifer, Jürgen Behr, Dagmar Kauschka, Andreas Günther, Felix J. F. Herth, Philipp Markart

European Respiratory Journal Sep 2019, 54 (suppl 63) PA4725; DOI: 10.1183/13993003.congress-2019.PA4725

Main menu

User menu

Search

idiopathic pulmonary fibrosis

Pages

Contact us